A MULTICENTER, OBSERVATIONAL POST-MARKET CLINICAL FOLLOW-UP STUDY IN PATIENTS WITH RA, PsA, OR axSpA ASSESSING THE PATIENT EXPERIENCE WITH THE CIMZIA AVA DEVICE OR OTHER TNF-BLOCKER AUTO-INJECTOR DEVICES

03/12/2019
02/07/2024
EU PAS number:
EUPAS32246
Study
Finalised
Documents
Study protocol
Study results
Study results
English (669.44 KB - PDF) View document
Study report
Other information